QUREHealthcareMid-Cap
uniQure N.V. Insider Trading Activity
Every SEC Form 4 insider transaction reported for uniQure N.V. (QURE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are QURE insiders buying or selling?
uniQure N.V. insiders reported 0 open-market buys ($0) and 233 sells ($77.8M) across 233 Form 4 filings — a net selling position of $77.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 7, 2026)
Total Form 4 filings
233
SEC EDGAR
Insider filers
21
Insider buys (0)
$0
Insider sells (233)
$77.8M
Insider sentiment
Net sellingNet insider flow of $77.8M in net selling.
Recent QURE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 21.1K | $45.16 | $952.1K |
| Jul 2, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 30.0K | $46.42 | $1.4M |
| Jul 2, 2026 | Jack Kaye | Director | Sale | 21.2K | $46.44 | $983.0K |
| Jun 30, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 1.4K | $46.86 | $67.2K |
| Jun 26, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 35.4K | $50.02 | $1.8M |
| Jun 22, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 206.1K | $45.47 | $9.4M |
| Jun 22, 2026 | Madhavan Balachandran | Director | Sale | 11.7K | $45.06 | $526.5K |
| Jun 22, 2026 | Jack Kaye | Director | Sale | 5.3K | $42.57 | $225.4K |
| Jun 17, 2026 | Madhavan Balachandran | Director | Sale | 10.0K | $27.85 | $278.5K |
| Jun 17, 2026 | Jeannette Potts | Chief Legal Officer | Sale | 5.2K | $27.67 | $144.9K |
| Jun 12, 2026 | David D. Meek | Director | Sale | 2.0K | $27.06 | $53.9K |
| Jun 12, 2026 | Robert Gut | Director | Sale | 10.3K | $26.32 | $270.5K |
| Jun 12, 2026 | Kylie O'Keefe | Chief Customer & Strat Officer | Sale | 15.9K | $27.06 | $431.2K |
| Jun 12, 2026 | Jeremy P. Springhorn | Director | Sale | 2.0K | $27.06 | $53.9K |
| Jun 12, 2026 | Leonard E Post | Director | Sale | 2.0K | $27.06 | $53.9K |
| Jun 12, 2026 | Jack Kaye | Director | Sale | 2.0K | $27.06 | $53.9K |
| Jun 12, 2026 | Rachelle Suzanne Jacques | Director | Sale | 2.0K | $27.06 | $53.9K |
| Jun 12, 2026 | Madhavan Balachandran | Director | Sale | 2.0K | $27.06 | $53.9K |
| Jun 5, 2026 | Jack Kaye | Director | Sale | 2.6K | $30.01 | $79.4K |
| May 12, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 45.0K | $25.06 | $1.1M |
| Mar 6, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 14.6K | $9.06 | $132.1K |
| Mar 6, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 808 | $9.06 | $7.3K |
| Mar 6, 2026 | Jeannette Potts | Chief Legal Officer | Sale | 3.4K | $9.06 | $30.9K |
| Mar 6, 2026 | Christian Klemt | Chief Financial Officer | Sale | 12.0K | $9.06 | $108.7K |
| Mar 4, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 34.4K | $9.95 | $342.6K |
Showing the 25 most recent of 233 Form 4 filings for uniQure N.V..
Most active QURE insiders
- Matthew C Kapusta53 filings
- Alexander Edward Kuta III29 filings
- Christian Klemt25 filings
- Robert Gut16 filings
- Jack Kaye14 filings
Ask anything about QURE insider activity
Use Trabud's AI agent to query uniQure N.V.'s Form 4 history in plain English — "Show me QURE CEO purchases this year" or compare it against any other ticker.
Open the AI agentQURE insider trading FAQ
Are uniQure N.V. insiders buying or selling?
Across 233 SEC Form 4 filings, uniQure N.V. (QURE) insiders reported 0 open-market purchases totaling $0 and 233 sales totaling $77.8M. That is a net selling position of $77.8M.
How many insiders trade QURE stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for uniQure N.V.. The most recent filing was accepted on Jul 7, 2026.
Where does Trabud get QURE insider trading data?
All QURE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.